LEMAITRE VASCULAR, INC. Finance Lease, Right-of-Use Asset, after Accumulated Amortization
LEMAITRE VASCULAR, INC. (LMAT) had Finance Lease, Right-of-Use Asset, after Accumulated Amortization of $0 as of 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Balance Sheet › Assets
us-gaap:FinanceLeaseRightOfUseAsset · last filed 2023-08-08
- 2023-06-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $0.00.
- 2023-03-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $0.00.
- 2022-09-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $0.00.
- 2022-06-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $0.00.
| Period end | Finance Lease, Right-of-Use Asset, after Accumulated Amortization |
|---|---|
| 2023-06-30 | $0.00 10-Q · filed 2023-08-08 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-08 |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-05 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-10 |
| 2021-12-31 | $0.00 10-K · filed 2022-02-28 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-04 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-05 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-10 |
| 2020-12-31 | $0.00 10-K · filed 2021-03-12 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-06 |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-06 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-08 |
| 2019-12-31 | $0.00 10-K · filed 2020-03-12 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |